Clinical Trials Related to FOXG1 Research Foundation

Phase 1/2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS)

Status

ENROLLING_BY_INVITATION

Phase

PHASE1/PHASE2